NCT06755905View on ClinicalTrials.gov

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

December 15, 2024

Conditions
Lymphatic Malformation
Interventions
PROCEDURE

ICGL-guided treatment

Indocyanine green lymphography guided resection combined with sclerotherapy

PROCEDURE

Conventional Treatment group

Resection with sclerotherapy

Trial Locations (1)

210008

Children's hospital of nanjing medical university, Nanjing

All Listed Sponsors
lead

Nanjing Children's Hospital

OTHER

NCT06755905 - Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation | Biotech Hunter | Biotech Hunter